• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 382544
Device Problem Degraded (1153)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 05/22/2018
Event Type  malfunction  
Manufacturer Narrative
Initial reporter phone#: (b)(6).Initial reporter fax#: (b)(6).A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that the seal on a bd insyte¿ autoguard¿ shielded iv catheter appears degraded, packets opening spontaneously therefore no longer sterile.No injury or medical intervention.
 
Manufacturer Narrative
Investigation summary: lot analysis lot 6119804 was built on afa line 9 on 06may2016 thru 10may2016 and packaged on packaging line 11 for the quantity of 428,210ea.Review of dhr revealed all required challenge samples and testing was conducted per specifications and in accordance with the in-process sampling plans.Review disclosed no reject activity findings throughout the build of this lot that would impact the outcome of the quality of the product relevant to the defect stated in the event description.Visual analysis observations and testing: received 2 insyte autoguard bc 18ga units from lot number 6119804 exp.2019-04-30.Visual/microscopic examination: both of the packages received were partially open at both ends.The product characteristics require a minimum of 1/8¿ seal width with adhesive transfer from the top web paper to the bottom web film.This characteristic was met.In addition the paper top web of the returned units was analyzed under uv light.The adhesive used to seal the top and bottom webs is uv fluorescent.The analysis revealed adequate top web adhesive.The key variables that affect seal strength are seal transfer/width and top web adhesive presence.Both of these variables were included in the investigation.Investigation samples(s) meet manufacturing specifications: yes; although the defect was confirmed, the unit evaluated for this incident was acceptable per the manufacturing specification requirements of the package.Investigation conclusion: the defect stated in the description of the complaint was confirmed with the returned unit.Even though the package was received partially opened, all the process characteristics that directly influence the seal were observed to be within specification.No anomalies were found.Root cause: relationship of device to the reported incident: indeterminate although the packages were observed to be partially opened, there was no physical evidence to confirm or to support manufacturing process related issues for the defect.Capa 48637 was initiated to address the issue of open seal complaints.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
MDR Report Key7613495
MDR Text Key111903895
Report Number1710034-2018-00300
Device Sequence Number1
Product Code FOZ
UDI-Device Identifier30382903825449
UDI-Public30382903825449
Combination Product (y/n)N
PMA/PMN Number
K110443
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 06/26/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/19/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date04/30/2019
Device Catalogue Number382544
Device Lot Number6119804
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/04/2018
Date Manufacturer Received05/25/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-